Search
for
Sort by
Research 601–630 of 1000+
- The need for African dermatology guidelines—Steps towards equitable care
- Chemotherapy-induced alopecia
- Understanding Melanocyte Stem Cells for Disease Modeling and Regenerative Medicine Applications
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- The Molecular Revolution in Cutaneous Biology: Noncoding RNAs: New Molecular Players in Dermatology and Cutaneous Biology
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- Biology of melanocytes in mammals
- KRDQN: An Interpretable Prediction Framework for Adverse Drug Reactions via Knowledge–Graph Reinforced Deep Q-Learning
- Vitiligo and alopecia areata: apples and oranges?
- Skipping of Exons by Premature Termination of Transcription and Alternative Splicing within Intron-5 of the Sheep SCF Gene: A Novel Splice Variant
- Alopecia areata
- Treatment options for polycystic ovary syndrome
- The JAK/STAT signaling pathway: from bench to clinic
- JAK inhibitors in dermatology: The promise of a new drug class
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Dermoscopy in General Dermatology: A Practical Overview
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Nanoparticles for Topical Application in the Treatment of Skin Dysfunctions—An Overview of Dermo-Cosmetic and Dermatological Products
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Frontiers in alopecia areata pathobiology research
- Resident Memory T Cells in Autoimmune Skin Diseases
- Primary cicatricial alopecia: diagnosis and treatment
- Plant-derived exosome-like nanovesicles: a novel therapeutic perspective for skin diseases
- Poliosis circumscripta: Overview and underlying causes
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Intralesional steroids for alopecia areata
- Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients
- Topical Administration of Drugs Incorporated in Carriers Containing Phospholipid Soft Vesicles for the Treatment of Skin Medical Conditions
- The Genetics of Human Skin Disease